Ruxolitinib: a game changer in paediatric chronic graft-versus-host disease management?

被引：0
|
作者：
Sisinni, Luisa [1 ]
机构：
[1] La Paz Univ Hosp, Pediat HSCT Unit, Madrid 28046, Spain
来源：
LANCET HAEMATOLOGY | 2024年 / 11卷 / 08期
关键词：
CRITERIA; CHILDREN;
D O I：
10.1016/S2352-3026(24)00206-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e553 / e555
页数：3
相关论文
共 50 条
  • [31] Clinical Benefit of Response in Chronic Graft-versus-Host Disease
    Inamoto, Yoshihiro
    Martin, Paul J.
    Chai, Xiaoyu
    Jagasia, Madan
    Palmer, Jeanne
    Pidala, Joseph
    Cutler, Corey
    Pavletic, Steven Z.
    Arora, Mukta
    Jacobsohn, David
    Carpenter, Paul A.
    Flowers, Mary E. D.
    Khera, Nandita
    Vogelsang, Georgia B.
    Weisdorf, Daniel
    Storer, Barry E.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (10) : 1517 - 1524
  • [32] ACUTE MYOFASCITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    Khan, Musa
    Ubogu, Eroboghene
    Alsharabati, Mohammad
    Salzman, Donna
    Mineishi, Shin
    Saad, Ayman
    MUSCLE & NERVE, 2016, 53 (02) : 327 - 329
  • [33] Novel Approaches to the Treatment of Chronic Graft-Versus-Host Disease
    Zeiser, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1820 - +
  • [34] Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease
    Alvarado, Savannah M.
    Cohen, Olivia G.
    Lattanzio, Katherine
    Haun, Paul
    Gelfand, Joel M.
    Loren, Alison W.
    Chung, Jina
    Baumrin, Emily
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2024, 46 (11) : 755 - 760
  • [35] Biomarkers in chronic graft-versus-host disease: quo vadis?
    Wolff, D.
    Greinix, H.
    Lee, S. J.
    Gooley, T.
    Paczesny, S.
    Pavletic, S.
    Hakim, F.
    Malard, F.
    Jagasia, M.
    Lawitschka, A.
    Hansen, J. A.
    Pulanic, D.
    Holler, E.
    Dickinson, A.
    Weissinger, E.
    Edinger, M.
    Sarantopoulos, S.
    Schultz, K. R.
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 832 - 837
  • [36] Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement
    Kaurinovic, Martina
    Delli, Konstantina
    Jonk, Ana-Mae E.
    Biswana, Anouschka
    Hazenberg, Carin L. E.
    Choi, Goda
    de Groot, Marco R.
    Morsink, Linde M.
    Vissink, Arjan
    Bellido, Mar
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (05) : 4209 - 4216
  • [37] Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
    Mahmoudjafari, Zahra
    Bhatt, Valkal
    Galvin, John
    Xue, Zhenyi
    Zeiser, Robert
    Locatelli, Franco
    Socie, Gerard
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2025, 60 (01) : 69 - 78
  • [38] Cutaneous graft-versus-host disease
    Cho, A.
    Just, U.
    Knobler, R.
    HAUTARZT, 2018, 69 (02): : 109 - 115
  • [39] Ocular graft-versus-host disease
    Dietrich-Ntoukas, T.
    Steven, P.
    OPHTHALMOLOGE, 2015, 112 (12): : 1027 - 1038
  • [40] Narrow-band UVB phototherapy for management of oral chronic graft-versus-host disease
    Treister, Nathaniel
    Li, Shuli
    Lerman, Mark A.
    Lee, Stephanie
    Soiffer, Robert
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2015, 31 (02) : 75 - 82
12345